Viewing Study NCT02105818


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-03-12 @ 10:30 AM
Study NCT ID: NCT02105818
Status: COMPLETED
Last Update Posted: 2017-04-13
First Post: 2014-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
Sponsor: Kurt Hersberger
Organization:

Study Overview

Official Title: Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis: a Cross-sectional Cohort Study
Status: COMPLETED
Status Verified Date: 2017-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SWAMECO
Brief Summary: The purpose of this study is the validation of a newly developed self-report questionnaire which aims at determining the prevalence, location and intensity of SWAllowing difficulties with drug intake, and describing the impact on MEdication regimen focusing on COping strategies (SWAMECO).
Detailed Description: The study aims at investigating a cohort of patients with diagnosed systemic sclerosis using the newly developed self-report SWAMECO-questionnaire.

The self-report questionnaire is sub-divided into four sections: detection of swallowing difficulties, coping strategies, risk factors to develop swallowing difficulties and adherence to medication.

This study involves patients with systemic sclerosis. Systemic sclerosis often is accompanied by swallowing disorders which may lead to issues in handling medication regimen with risks for patient safety.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: